Table IV.

VTE-BLEED score

Variable	Score
Factor
Active cancera	2
Male with uncontrolled arterial hypertensionb	1
Anemiac	1
History of bleedingd	1
Age ≥60 years	1
Renal dysfunctione	1
Classification
Low bleeding risk	<2
High bleeding risk	≥2
Other factors that contribute to bleeding	NA
Thrombocytopenia
Cirrhosis
Other antithrombotic use
Recent major surgery (eg, neurosurgery, laparotomy)

NA, Not applicable; VTE, venous thromboembolism.

^aCancer diagnosed within 6 months before VTE (excluding basal cell carcinoma or squamous cell carcinoma of the skin), recently recurrent or progressive cancer or any cancer that required anticancer treatment within 6 months before VTE diagnosis.

^bMen with systolic blood pressure ≥140 mm Hg at baseline.

^cHemoglobin <13 g/dL in men or <12 g/dL in women.

^dIncluding previous major or nonmajor clinically relevant bleeding event, rectal bleeding, frequent nose bleeding, or hematuria.

^eGlomerular filtration rate <60 mL/min.

Adapted from Klok FA, Barco S, Konstantinides SV. External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism. Thrombosis Haemost 2017; 117:1164-70.